Emerging strategies and translational advancements of DDR1 in oncology
Abstract Discoidin domain receptor 1 (DDR1) has emerged as a promising therapeutic target in oncology due to its unique role in tumor-stroma interactions and its involvement in key signaling pathways that drive cancer progression. DDR1 is homologous to the transmembrane receptor tyrosine kinase (RTK...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2025-03-01
|
| Schriftenreihe: | Discover Oncology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s12672-025-02107-z |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|